Key result
Preconditioned bone marrow stem cells reduce infarct size and improve LVEF post-MI in mice.
Answers are grounded in this paper and cite their sources.
In this study, we hypothesized that bone marrow stem cells (BMSCs) protect ischemic myocardium through paracrine effects that can be further augmented with preconditioning. In in vitro experiments, cell survival factors such as Akt and eNOS were significantly increased in BMSCs following anoxia. In the second series of experiments following coronary ligation in mice, left ventricles were randomly injected with the following: DMEM (G-1), BMSCs (G-2), and preconditioned BMSCs (G-3). Four days after myocardial infarction, BMSCs were observed within injured myocardium in G-2 and G-3. Apoptotic cardiomyocytes within periinfarct area were significantly reduced in G-3. Four weeks after myocardial infarction, smaller left ventricular (LV) dimension and increased LV ejection fraction were observed in G-3. Infarct area was significantly reduced in G-3. However, GFP+ cardiomyocytes were observed in low numbers within periinfarct area in G-2 and G-3. In conclusion, BMSCs secreted cell survival factors under ischemia, and they prevented apoptosis in cardiomyocytes adjacent to the infarcted area. Preconditioning of BMSCs enhanced their survival and ability to attenuate LV remodeling, which was attributable, in part, to paracrine effects.
No takes yet. Share an insight, caveat, or question.
Uemura et al. (2006) studied Myocardial infarction / ischemic heart disease (mouse model). Preconditioned bone marrow stem cells (BMSCs) or standard BMSCs vs. DMEM injection was evaluated on Left ventricular remodeling (LV dimension, LV ejection fraction, infarct area, and cardiomyocyte apoptosis). Preconditioned bone marrow stem cells reduced infarct area andLV dimension while increasing LV ejection fraction at 4 weeks post-MI in mice compared with DMEM.
Synapse has enriched 10 related papers. Consider them for comparative context: